Publication | Closed Access

Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial

UrologyOncologyGenitourinary CancerMedicineMetronomic TherapyMetronomic ChemotherapyCancer TreatmentPharmacologyMetronomic CapecitabineFinal Results